First month after infection is key time to tackle drug-related HIV spread

November 8, 2016, University of Oxford
HIV infecting a human cell. Credit: NIH

Data from the mid-1990s AIDS epidemic in Russia and Ukraine shows that the first month after infection is the key period to control the spread of the virus in drug-using populations, according to a new study by researchers at Oxford University. Crucially, needle exchange programmes and other 'harm reduction' approaches are the only measures that can target transmissions that happen within the first month.

HIV epidemics in people who inject drugs have been on the rise in recent years, including cases in Indiana, USA and Glasgow, UK, raising the question of which measures should be prioritised by authorities - particularly in regions with limited resources, such as the recently affected areas of the Middle East, northern Africa and southeastern Asia.

The research is published in the journal AIDS.

Lead author Tetyana Vasylyeva, a doctoral candidate in the Department of Zoology at Oxford University, said: "The HIV epidemic among in Russia and Ukraine following the collapse of the Soviet Union is the biggest of its kind ever recorded. From around only 50 cases per year by 1993, the epidemic grew to several thousand cases in 1994. By the end of the decade, over 1 million people were infected across the two countries—the majority of them drug users.

"There was very little in the way of a preventive effort in this epidemic, which makes it a good model to study."

The researchers analysed all publicly available HIV genetic sequences sampled in Russia and Ukraine from 1993 to 2013 and combined this information with UN prevalence estimates relating to the epidemic. They fed this data into complex mathematical models to allow them to reconstruct the history of the virus and predict, based on the transmission timeline, which interventions would be most effective among drug users. During their analysis, the researchers found that each HIV-infected drug user infected another ten people with the virus, with the infection generally being passed on within the first month of it being contracted.

Tetyana Vasylyeva added: "Without the right interventions, the spread of HIV among drug-using populations is a public health timebomb.

"While it's still very important to get recently infected people into treatment, we have shown that harm reduction measures are crucial to controlling the spread of the virus. Treatment on its own is not effective enough."

Senior author Dr Gkikas Magiorkinis, also of Oxford's Department of Zoology, said: "Drug users are a very difficult group in which to study the transmission of infections such as HIV. We have shown that there is a crucial window of intervention when a potential can be controlled.

"The key finding of this study is that identifying recently infected people is the most important intervention we can make.

"There is also an important policy message here around the support of needle exchange programmes."

Explore further: Official: Fourth-largest city in Russia has HIV epidemic

More information: The paper 'Mitigating HIV in people who inject drugs is impossible without targeting recently-infected: what we learned from Russia and Ukraine' is published in the journal AIDS on Wednesday 9 November 2016.

Related Stories

Official: Fourth-largest city in Russia has HIV epidemic

November 2, 2016
Russian health officials say one in 50 people in the country's fourth-largest city is carrying the HIV virus as Russia struggles to deal with a rapidly rising number of infections.

Quest to end AIDS epidemic at risk: UN

July 12, 2016
Efforts to end the global AIDS pandemic by 2030 are lagging, the UN warned Tuesday, decrying rising numbers of new HIV infections among adults in many regions, with Russia especially hard-hit.

Russia warns of two million HIV carriers in five years

May 14, 2015
Russia's AIDS epidemic is worsening and at least two million people are likely to be infected with HIV in about five years as the virus increasingly affects the heterosexual population, the country's top AIDS specialist said ...

AIDS: Crimean drug users at risk, says NGO

March 20, 2014
More than 14,000 injecting drug users in Crimea risk being cut off from life-saving treatment and services prohibited in Russia, an NGO working to halt HIV spread warned on Thursday.

UN plan to end AIDS by 2030 faces Russian resistance

June 8, 2016
UN member-states agreed on Wednesday to fast-track their response to end the AIDS pandemic by 2030 despite a last-minute bid by Russia to dilute efforts to focus on drug users and gay men.

Recommended for you

Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

September 21, 2018
Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously ...

FRESH program combines basic science with social benefits for women at risk of HIV

September 14, 2018
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from ...

New study finds HIV outbreak in Indiana could have been prevented

September 13, 2018
An HIV outbreak among people who inject drugs in Indiana from 2011 to 2015 could have been avoided if the state's top health and elected officials had acted sooner on warnings, a new study by the Yale School of Public Health ...

Largest study of 'post-treatment controllers' reveals clues about HIV remission

September 13, 2018
Most HIV patients need to take daily anti-retroviral therapy—if they suspend treatment, HIV will rebound within 3-4 weeks. But clinical trials have revealed that a small fraction of patients can stop taking medications ...

Very few sexually active gay and bisexual men use prophylactic drug to prevent HIV transmission, study finds

September 12, 2018
Only 4 percent of sexually active gay and bisexual men in the United States use Truvada, a highly effective medication used to prevent the transmission of HIV, according to the results of a first-of-its-kind study.

Special antibodies could lead to HIV vaccine

September 10, 2018
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.